Local passive transfer of delayed type hypersensitivity to syngeneic testicular cells in mice. 1984

Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto

A means for local passive transfer (LPT) of delayed footpad reaction (DFR) against syngeneic testicular cells (TC) was established in mice. Peritoneal exudate (PE) cells from immunized donors pre-treated with cyclophosphamide (Cy) were transferred with syngeneic TC into a hind footpad of a naive mouse. Antigen specific DFR was successfully transferred by PE cells as early as 3-5 days after immunization and as late as 39 days after immunization. DFR was abolished after treatment of PE cells with anti-0 serum, indicating T cell dependence. No footpad reaction can be elicited in male mice immunized with syngeneic TC without Cy pre-treatment. However, PE cells of those mice can passively transfer footpad reaction locally, suggesting the existence of suppressive mechanism in the donors. Although no suppressive mechanism was disclosed at the present, this LPT system seems a potent tool for further analysis of the regulatory mechanisms.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids

Related Publications

Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
July 1982, Journal of immunology (Baltimore, Md. : 1950),
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
June 1994, The Journal of antibiotics,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
March 1981, Immunology,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
January 1984, International archives of allergy and applied immunology,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
December 1985, Infection and immunity,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
January 1952, Annals of allergy,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
October 1974, Infection and immunity,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
January 1979, International archives of allergy and applied immunology,
Y Sakamoto, and H Sanui, and S Yoshida, and K Nomoto
September 1972, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
Copied contents to your clipboard!